Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.
作者信息
Lai Quirino, De Stefano Carmine, Emond Jean, Bhangui Prashant, Ikegami Toru, Schaefer Benedikt, Hoppe-Lotichius Maria, Mrzljak Anna, Ito Takashi, Vivarelli Marco, Tisone Giuseppe, Agnes Salvatore, Ettorre Giuseppe Maria, Rossi Massimo, Tsochatzis Emmanuel, Lo Chung Mau, Chen Chao-Long, Cillo Umberto, Ravaioli Matteo, Lerut Jan Paul
机构信息
General Surgery and Organ Transplantation Unit, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Data Science and Engineering, Polytechnic of Turin, Turin, Italy.
出版信息
Cancer Commun (Lond). 2023 Dec;43(12):1381-1385. doi: 10.1002/cac2.12468. Epub 2023 Oct 30.
Abstract
摘要
相似文献
1
Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.一种用于预测移植后肝细胞癌复发的人工智能模型的开发与验证
Cancer Commun (Lond). 2023 Dec;43(12):1381-1385. doi: 10.1002/cac2.12468. Epub 2023 Oct 30.
2
Reply to the letter 'Preoperative MRI in predicting tumour recurrence of hepatocellular carcinoma: Does AI have a role?'.对信件《术前磁共振成像在预测肝细胞癌肿瘤复发中的作用：人工智能是否有一席之地？》的回复
Liver Int. 2024 Jul;44(7):1738. doi: 10.1111/liv.15957. Epub 2024 May 25.
3
Artificial neural network model to predict post-hepatectomy early recurrence of hepatocellular carcinoma without macroscopic vascular invasion.基于人工神经网络的模型预测无大血管侵犯肝癌术后早期复发。
BMC Cancer. 2021 Mar 16;21(1):283. doi: 10.1186/s12885-021-07969-4.
4
Single-Center Experience of Recurrence Patterns and Survival Analyses of Patients With Hepatocellular Carcinoma and Liver Transplant.肝细胞癌肝移植患者的复发模式和生存分析的单中心经验
Exp Clin Transplant. 2020 Apr;18(2):201-205. doi: 10.6002/ect.2020.0046.
5
Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.原位肝移植后肝细胞癌的发病率及危险因素
Surgery. 2017 Mar;161(3):830-836. doi: 10.1016/j.surg.2016.08.049. Epub 2016 Oct 19.
6
Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.肝移植后丙型肝炎的快速纤维化和显著组织学复发与丙型肝炎病毒相关肝病所致肝细胞癌的更高肿瘤复发率相关：一项单中心回顾性分析。
Exp Clin Transplant. 2015 Feb;13(1):46-50.
7
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.同型半胱氨酸：甲胎蛋白阴性肝细胞癌肝移植的新型预后生物标志物。
Cancer Biomark. 2020;29(2):197-206. doi: 10.3233/CBM-201545.
8
EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Post-transplant recurrence of fibrolamellar hepatocellular carcinoma in lung and pancreas.教育与影像学。肝胆胰：纤维板层型肝细胞癌移植后在肺和胰腺的复发
J Gastroenterol Hepatol. 2016 Feb;31(2):286. doi: 10.1111/jgh.13048.
9
Outcomes of Patients With Hepatocellular Carcinoma After Liver Transplant.肝移植后肝细胞癌患者的预后
Exp Clin Transplant. 2015 Nov;13 Suppl 3:30-2. doi: 10.6002/ect.tdtd2015.O22.
10
Imaging of hepatocellular carcinoma recurrence post liver resection: a pictorial essay.肝切除术后肝细胞癌复发的影像学表现：图文综述
J Med Imaging Radiat Oncol. 2013 Jun;57(3):337-44. doi: 10.1111/j.1754-9485.2012.02468.x. Epub 2012 Oct 29.
引用本文的文献
1
Validation of the Toronto recurrence inference using machine-learning for post-transplant hepatocellular carcinoma model.使用机器学习对移植后肝细胞癌模型进行多伦多复发推断的验证。
Commun Med (Lond). 2025 Jul 9;5(1):284. doi: 10.1038/s43856-025-00994-5.
2
[Recent Advances in Peripheral Immunoscore in Lung Cancer].[肺癌外周免疫评分的最新进展]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):379-384. doi: 10.3779/j.issn.1009-3419.2025.102.21.
3
Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation.用于预测肝移植候选肝细胞癌患者微血管侵犯的移植前风险评分（LT-MVI评分）的开发与验证
Cancers (Basel). 2025 Apr 24;17(9):1418. doi: 10.3390/cancers17091418.
4
Evolving Transplant Oncology: Evolving Criteria for Better Decision-Making.不断发展的移植肿瘤学：用于更好决策的不断演变的标准。
Diagnostics (Basel). 2025 Mar 24;15(7):820. doi: 10.3390/diagnostics15070820.
5
A prospective multicenter validation of RETREAT for posttransplantation HCC recurrence prediction.RETREAT用于肝移植术后肝癌复发预测的前瞻性多中心验证
Hepatology. 2025 Mar 11. doi: 10.1097/HEP.0000000000001297.
6
The role of the comprehensive complication index in the prediction of tumor-related death in transplanted patients with hepatocellular carcinoma.综合并发症指数在预测肝细胞癌移植患者肿瘤相关死亡中的作用。
Updates Surg. 2025 Feb 10. doi: 10.1007/s13304-025-02101-8.
7
Application progress of artificial intelligence in tumor diagnosis and treatment.人工智能在肿瘤诊疗中的应用进展
Front Artif Intell. 2025 Jan 7;7:1487207. doi: 10.3389/frai.2024.1487207. eCollection 2024.
本文引用的文献
1
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach.多伦多肝移植后肝细胞癌复发计算器：一种机器学习方法。
Liver Transpl. 2022 Apr;28(4):593-602. doi: 10.1002/lt.26332. Epub 2021 Nov 5.
2
Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning: A Multicenter Study.使用深度学习获得的预测肝移植后肝癌复发的新型模型：一项多中心研究
Cancers (Basel). 2020 Sep 29;12(10):2791. doi: 10.3390/cancers12102791.
3
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study.肝癌伴大血管侵犯经治疗后行肝移植的多中心回顾性队列研究。
Transpl Int. 2020 May;33(5):567-575. doi: 10.1111/tri.13586. Epub 2020 Feb 20.
4
Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.为肝癌肝移植的风险预测绘制前进道路：4089 例患者中 HALTHCC 的国际验证。
Hepatology. 2020 Feb;71(2):569-582. doi: 10.1002/hep.30838. Epub 2019 Aug 19.
5
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.Metroticket 2.0 模型分析肝癌肝移植术后死亡的竞争风险。
Gastroenterology. 2018 Jan;154(1):128-139. doi: 10.1053/j.gastro.2017.09.025. Epub 2017 Oct 5.
6
Predicting the Future - Big Data, Machine Learning, and Clinical Medicine.预测未来——大数据、机器学习与临床医学。
N Engl J Med. 2016 Sep 29;375(13):1216-9. doi: 10.1056/NEJMp1606181.
7
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score.一种新型的肝癌患者肝移植等待期预后指标：时间-影像学-甲胎蛋白-炎症（TRAIN）评分。
Ann Surg. 2016 Nov;264(5):787-796. doi: 10.1097/SLA.0000000000001881.
8
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.肝癌肝移植：包含甲胎蛋白的模型可改善米兰标准的性能。
Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.
9
A time-dependent discrimination index for survival data.生存数据的时间依赖性判别指数。
Stat Med. 2005 Dec 30;24(24):3927-44. doi: 10.1002/sim.2427.
10
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.肝移植治疗肝硬化患者的小肝细胞癌
N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104.
Zotero 插件